Breaking Finance News

A report released today by B. Riley about Heska Corp (NYSE:HSKA) bumps the target price to $53.00

Heska Corp (NYSE:HSKA) had its stock price target increased to $53.00 by B. Riley in a report released 9/21/2016. The new stock price target suggests a potential downside of -0.05% from the company's most recent close.

Yesterday Heska Corp (NYSE:HSKA) traded -0.40% lower at $55.68. HSKA’s 50-day average is $52.90 and its two hundred day average is $39.60. With the last close up 37.54% from the 200-day moving average, compared to the Standard & Poor's 500 Index which has decreased -0.01% over the same time. 94,798 shares of Heska Corp exchanged hands, down from an average trading volume of 100,917

Performance Chart

Heska Corp (NYSE:HSKA)

Heska Corp has P/E ratio of 55.18 with a 52 week low of $26.26 and a 52 week high of $57.41 and has a market capitalization of $0.

A total of 4 firms have reported on the stock. One firm rating the stock a strong buy, three analysts rating the stock a buy, 0 brokerages rating the stock a hold, 0 firms rating the stock a underperform, and finally zero equity analysts rating the company a sell with a one year target of $39.88.

General Company Details For Heska Corp (NYSE:HSKA)

Heska Corporation develops, manufactures, markets, sells and supports veterinary products. The Company focuses on the canine and feline companion animal health markets. Its segments include Core Companion Animal Health segment, which includes, primarily for canine and feline use, blood testing instruments and supplies, digital imaging products, software and services, and single use products and services, such as heartworm diagnostic tests, heartworm preventive products, allergy immunotherapy products and allergy testing, and Other Vaccines, Pharmaceuticals and Products segment, which includes private label vaccine and pharmaceutical production, primarily for cattle but also for other animals, including small mammals. It offers blood testing instruments and supplies, digital imaging products, software and services, and single use products and services, such as in-clinic heartworm diagnostic tests, heartworm preventive products, allergy immunotherapy products and allergy testing.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *